Pfizer
PFE
PFE
3,076 hedge funds and large institutions have $169B invested in Pfizer in 2022 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 1,353 increasing their positions, 1,227 reducing their positions, and 168 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $201B → $169B (-$32B)
18% less first-time investments, than exits
New positions opened: 138 | Existing positions closed: 168
38% less funds holding in top 10
Funds holding in top 10: 251 → 156 (-95)
Holders
3,076
Holding in Top 10
156
Calls
$2.73B
Puts
$2.07B
Top Buyers
| 1 | +$507M | |
| 2 | +$292M | |
| 3 | +$286M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$250M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$193M |
Top Sellers
| 1 | -$403M | |
| 2 | -$180M | |
| 3 | -$131M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$128M |
| 5 |
BlackRock
New York
|
-$123M |